Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, adding two more study numbers and indicating that the study now has 216 locations, while the previous version 2.9.7 has been removed.
    Difference
    0.3%
    Check dated 2024-07-22T14:56:26.000Z thumbnail image
  6. Check
    8 days ago
    Change Detected
    Summary
    The website now displays the actual last update posted instead of an estimated time, providing more accurate information to users.
    Difference
    0.0%
    Check dated 2024-07-19T12:12:01.000Z thumbnail image
  7. Check
    9 days ago
    Change Detected
    Summary
    The website has added new recruiting hospitals in Brazil, Japan, and Switzerland, with the latest update posted on July 15, 2024.
    Difference
    1.0%
    Check dated 2024-07-18T12:00:15.000Z thumbnail image
  8. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T10:15:33.000Z thumbnail image
  9. Check
    25 days ago
    Change Detected
    Summary
    The value of Last Update Posted (Estimated) Revision has changed from v2.9.5 to v2.9.6, indicating an update in the study record for the clinical trial comparing Elranatamab versus Lenalidomide in patients with newly diagnosed multiple myeloma after transplant.
    Difference
    0.1%
    Check dated 2024-07-01T18:55:17.000Z thumbnail image
  10. Check
    28 days ago
    Change Detected
    Summary
    The value of the study record has been updated to reflect a Phase 3 study comparing Elranatamab versus Lenalidomide in patients with newly diagnosed Multiple Myeloma after undergoing autologous stem cell transplant. The last update was posted on 2024-06-28 with a revision to v2.9.5.
    Difference
    2%
    Check dated 2024-06-29T16:34:55.000Z thumbnail image

Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.